CNS Pharmaceuticals (CNSP) Current Assets (2018 - 2025)
CNS Pharmaceuticals (CNSP) recorded Current Assets of $8.1 million in Q4 2025, down 6.4% from $8.66 million a year earlier and down 28.9% from the prior quarter.
Powered by 
Analysis
CNS Pharmaceuticals (CNSP) Current Assets (2018 - 2025) Analysis & Trends
Starting with Q4 2018, CNS Pharmaceuticals' Current Assets history includes 27 quarters.
- Annual Current Assets has a five-year compound annual growth rate of -12.2% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $8.66 million in FY2024 (+444.2%), $1.59 million in FY2023 (-87.3%), $12.56 million in FY2022 (+68.0%) and $7.48 million in FY2021 (-51.7%).
- The Q4 2025 figure is the lowest quarterly Current Assets since Q3 2024.
- On a year-over-year basis, Current Assets rose in five of the last eight quarters, with growth averaging 240.6%.
- Peak year-over-year performance for Current Assets in the last five years was growth of 756.9% in Q1 2025, against a decline of 87.3% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $11.39 million (Q3 2025), $14.14 million (Q2 2025) and $13.72 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | CNS Pharmaceuticals | 2.14 Mn | -40.10 Mn | - | 8.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 8.10 Mn |
| Sep 30, 2025 | 11.39 Mn |
| Jun 30, 2025 | 14.14 Mn |
| Mar 31, 2025 | 13.72 Mn |
| Dec 31, 2024 | 8.66 Mn |
| Sep 30, 2024 | 7.39 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 2.06 Mn |
| Jun 30, 2023 | 6.07 Mn |
| Mar 31, 2023 | 6.97 Mn |
| Dec 31, 2022 | 12.56 Mn |
| Sep 30, 2022 | 8.70 Mn |
| Jun 30, 2022 | 11.40 Mn |
| Mar 31, 2022 | 14.73 Mn |
| Dec 31, 2021 | 7.48 Mn |
| Sep 30, 2021 | 11.16 Mn |
| Jun 30, 2021 | 13.88 Mn |
| Mar 31, 2021 | 12.79 Mn |
API Access
CNS Pharmaceuticals Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CNSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CNSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CNSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();